Abgenix And Diabetogen Sign Second Agreement To Develop Antibody Therapy Against Autoimmune Disease
16-Apr-2002 -
Fremont, Calif. and London, Ontario, Canada - Abgenix, Inc., an antibody-based biopharmaceutical company, and Diabetogen Biosciences, Inc., a privately-held biotechnology company, announced today the execution of a research collaboration, option and license agreement to discover and develop a ...
Abgenix
antibodies
antigens
+13